The contribution of different formulation components on the aerosol charge in carrier-based dry powder inhaler systems

Pharmaceutical Research

Volumn 27, Issue 7, 2010, Pages 1325-1336

  Hoe, Susan ^a   Traini, Daniela ^a   Chan, Hak Kim ^a   Young, Paul M ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Cyclohaler ; Electrical next generation impactor (eNGI); Electrostatic; Lactose; Salbutamol sulphate

Indexed keywords

GELATIN; LACTOCHEM; LACTOSE; SALBUTAMOL SULFATE; UNCLASSIFIED DRUG; BRONCHODILATING AGENT; DRUG CARRIER; POWDER; SALBUTAMOL;

AEROSOL; ARTICLE; CAPSULE FILLING; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRY POWDER; GELATINIZATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LASER DIFFRACTION; PARTICLE SIZE; POWDER INHALER; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; ADMINISTRATION AND DOSAGE; CHEMISTRY; INHALATIONAL DRUG ADMINISTRATION; MEDICINAL CHEMISTRY; NEBULIZER; POWDER; STATIC ELECTRICITY;

ADMINISTRATION, INHALATION; ALBUTEROL; BRONCHODILATOR AGENTS; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG CARRIERS; LACTOSE; MICROSCOPY, ELECTRON, SCANNING; NEBULIZERS AND VAPORIZERS; PARTICLE SIZE; POWDERS; STATIC ELECTRICITY;

EID: 77953610016     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-010-0115-9     Document Type: Article

References (33)

1. N Islam P Stewart I Larson P Hartley 2005 Surface roughness contribution to the adhesion force distribution of salmeterol xinafoate on lactose carriers by atomic force microscopy J Pharm Sci 94 1500 1511 10.1002/jps.20381 1:CAS:528:DC%2BD2MXlslCrt7k%3D 15924347 (Pubitemid 41168680)
2. PM Young P Kwok H Adi H-K Chan D Traini 2009 Lactose composite carriers for repiratory delivery Pharm Res 26 802 810 10.1007/s11095-008-9779-9 1:CAS:528:DC%2BD1cXhtlyjtLzL 19015956
3. P Harjunen T Lankinen H Salonen V-P Lehto K Järvinen 2003 Effects of carriers and storage of formulation on the lung deposition of a hydrophobic and hydrophilic drug from a DPI Int J Pharm 263 151 163 10.1016/S0378-5173(03) 00357-0 1:CAS:528:DC%2BD3sXmvValtb8%3D 12954190 (Pubitemid 37087942)
4. PM Young A Sung D Traini P Kwok H Chiou H-K Chan 2007 Influence of humidity on the electrostatic charge and aerosol performance of dry powder inhalers carrier-based systems Pharm Res 24 963 970 10.1007/s11095-006-9218-8 1:CAS:528:DC%2BD2sXkslWgt7o%3D 17377746 (Pubitemid 46680220)
5. M Lohrmann M Kappl H-J Butt NA Urbanetz BC Lippold 2007 Adhesion forces in interactive mixtures for dry powder inhalers-evaluation of a new measuring method Eur J Pharm Biopharm 67 579 586 10.1016/j.ejpb.2007.02.011 1:CAS:528:DC%2BD2sXovFyrs7s%3D 17418548 (Pubitemid 47211901)
6. XM Zeng GP Martin C Marriott J Pritchard 2001 Lactose as a carrier in dry powder formulations: the influence of surface characteristics on drug delivery J Pharm Sci 90 1424 1434 10.1002/jps.1094 1:CAS:528:DC%2BD3MXmvFGjsL8%3D 11745794 (Pubitemid 32867990)
7. N Islam P Stewart I Larson P Hartley 2004 Effect of carrier size on the dispersion of salmeterol xinafoate from interactive mixtures J Pharm Sci 93 1030 1038 10.1002/jps.10583 1:CAS:528:DC%2BD2cXivF2ltrk%3D 14999738 (Pubitemid 38420412)
8. SK Tee C Marriott XM Zeng GP Martin 2000 The use of different sugars as fine and coarse carriers for aerosolised salbutamol sulphate Int J Pharm 208 111 123 10.1016/S0378-5173(00)00553-6 1:CAS:528:DC%2BD3cXosVGjtr0%3D 11064216
9. H Adi I Larson H Chiou P Young D Traini P Stewart 2007 Role of agglomeration in the dispersion of salmeterol xinafoate from mixtures for inhalation with differing drug to fine lactose ratios J Pharm Sci 97 3140 3152 10.1002/jps.21228
10. XM Zeng GP Martin C Marriott J Pritchard 2000 The effects of carrier size and morphology on the dispersion of salbutamol sulphate after aerosolization at different flow rates J Pharm Pharmacol 52 1211 1221 10.1211/0022357001777342 1:CAS:528:DC%2BD3cXot1Ortbs%3D 11092565
11. XM Zeng GP Martin C Marriott J Pritchard 2000 The influence of carrier morphology on drug delivery by dry powder inhalers Int J Pharm 200 93 106 10.1016/S0378-5173(00)00347-1 1:CAS:528:DC%2BD3cXktFarsb4%3D 10845690 (Pubitemid 30177254)
12. H Adi D Traini H-K Chan PM Young 2007 The influence of drug morphology on aerosolisation efficiency of dry powder inhaler formulations J Pharm Sci 97 2780 2788 10.1002/jps.21195
13. C Melandri G Tarroni V Prodi T de Zaiacomo M Formignani CC Lombardi 1983 Deposition of charged particles in the human airways J Aerosol Sci 14 657 669 10.1016/0021-8502(83)90070-8 (Pubitemid 14192210)
14. V Prodi A Mularoni 1985 Electrostatic lung deposition experiments with humans and animals Ann Occup Hyg 29 229 240 10.1093/annhyg/29.2.229 1:STN:280:DyaL28%2FkvFSlsA%3D%3D 4062149
15. AG Bailey AH Hashish TJ Williams 1998 Drug delivery by inhalation of charged particles J Electrostat 44 3 10 10.1016/S0304-3886(98)00017-5 1:CAS:528:DyaK1cXjs12htro%3D
16. W Balachandran W Machowski E Gaura C Hudson 1997 Control of drug aerosol in human airways using electrostatic forces J Electrostat 40 & 41 579 584 10.1016/S0304-3886(97)00106-X
17. PR Byron J Peart J Staniforth 1997 Aerosol electrostatics I: properties of fine powders before and after aerosolisation by dry powder inhalers Pharm Res 14 698 705 10.1023/A:1012181818244 1:CAS:528:DyaK2sXkt1yitrc%3D 9210184 (Pubitemid 27281661)
18. KT Chow K Zhu RBH Tan PWS Heng 2008 Investigation of electrostatic behavior of a lactose carrier for dry powder inhalers Pharm Res 25 2822 2834 10.1007/s11095-008-9651-y 1:CAS:528:DC%2BD1cXhsVeqs77M 18581205
19. PCL Kwok H-K Chan 2008 Effect of relative humidity on the electrostatic charge properties of dry powder inhaler aerosols Pharm Res 25 277 288 10.1007/s11095-007-9377-2 1:CAS:528:DC%2BD1cXitVejt7c%3D 17619997 (Pubitemid 351257975)
20. MJ Telko J Kujanpää AJ Hickey 2007 Investigation of triboelectric charging in dry powder inhalers using electrical low pressure impactor (ELPI) Int J Pharm 336 352 360 10.1016/j.ijpharm.2006.12.018 1:CAS:528:DC%2BD2sXkvFajs7w%3D 17218072 (Pubitemid 46670665)
21. M Crampton R Kinnersley J Ayres 2004 Sub-micrometer particle production by pressurised metered dose inhalers J Aerosol Med 17 33 42 10.1089/ 089426804322994442 1:CAS:528:DC%2BD2cXjtFaks7s%3D 15120011 (Pubitemid 38520671)
22. W Glover H-K Chan 2004 Electrostatic charge characterization of pharmaceutical aerosols using electrical low-pressure impactor (ELPI) J Aerosol Sci 35 755 764 10.1016/j.jaerosci.2003.12.003 1:CAS:528:DC%2BD2cXkt1Wlurs%3D (Pubitemid 38668673)
23. J Keskinen K Pietarinen M Lehtimäki 1992 Electrical low pressure impactor J Aerosol Sci 23 353 360 10.1016/0021-8502(92)90004-F 1:CAS:528:DyaK38XltlensLg%3D
24. Chapter <601>. United States Pharmacopoeia 31-National Formulary 26, United States Pharmacopoeial Convention Inc., 2008.
25. Section 2.9.18-Appendix XII C. Consistency of formulated preparations for inhalation., British Pharmacopoeia, Vol. IV, 2009.
26. S Hoe D Traini H-K Chan P Young 2009 The influence of flow rate on the aerosol deposition profile and electrostatic charge of single and combination metered dose inhalers Pharm Res 26 2639 2646 10.1007/s11095-009-9979-y 1:CAS:528:DC%2BD1MXhtlCrtbzM 19806433
27. S Hoe D Traini H-K Chan PM Young 2009 Measuring charge and mass distributions in dry powder inhalers using the electrical Next Generation Impactor (eNGI) Eur J Pharm Sci 38 88 94 10.1016/j.ejps.2009.06.003 1:CAS:528:DC%2BD1MXhtVentb7L 19559086
28. S Hoe PM Young H-K Chan D Traini 2009 Introduction of the electrical Next Generation Impactor (eNGI) and investigation of its capabilities for the study of pressurized metered dose inhalers Pharm Res 26 431 437 10.1007/s11095-008- 9761-6 1:CAS:528:DC%2BD1cXhtlyjtLzI 19015961
29. VA Marple DL Roberts FJ Romay NC Miller KG Truman M van Oort B Olsson MJ Holroyd JP Mitchell D Hochrainer 2003 Next generation pharmaceutical impactor (a new impactor for pharmaceutical inhaler testing). Part I: design J Aerosol Med 16 283 299 10.1089/089426803769017659 14572326 (Pubitemid 37169639)
30. J Lowell AC Rose-Innes 1980 Contact electrification Adv Phys 29 947 1023 10.1080/00018738000101466 1:CAS:528:DyaL3MXls1CksQ%3D%3D
31. XM Zeng GP Martin S-K Tee C Marriott 1998 The role of fine particle lactose on the dispersion and deaggregation of salbutamol sulphate in an air stream in vitro Int J Pharm 176 99 110 10.1016/S0378-5173(98)00300-7 1:CAS:528:DyaK1cXntlymtLg%3D (Pubitemid 28544976)
32. PA Young S Edge D Traini MD Jones R Price D El-Sabawi C Urry C Smith 2005 The influence of dose on the performance of dry powder inhalation systems Int J Pharm 296 26 33 10.1016/j.ijpharm.2005.02.004 1:CAS:528:DC%2BD2MXktVais7g%3D 15885452 (Pubitemid 40693369)
33. D Traini PM Young F Thielmann M Acharya 2008 The influence of lactose pseudopolymorphic form on salbutamol sulfate-lactose interactions in DPI formulations Drug Dev Ind Pharm 34 992 1001 10.1080/03639040802154889 1:CAS:528:DC%2BD1cXhtFais77J 18800259